Controversies in using urine samples for prostate cancer detection: PSA and PCA3 expression analysis

Detalhes bibliográficos
Autor(a) principal: Fontenete,S.
Data de Publicação: 2011
Outros Autores: Silva,J., Teixeira,A. L., Ribeiro,R., Bastos,E., Pina,F., Medeiros,R.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: International Braz J Urol (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382011000600006
Resumo: PURPOSE: Prostate cancer (PCa) is one of the most commonly diagnosed malignancies in the world. Although PSA utilization as a serum marker has improved prostate cancer detection it still presents some limitations, mainly regarding its specificity. The expression of this marker, along with the detection of PCA3 mRNA in urine samples, has been suggested as a new approach for PCa detection. The goal of this work was to evaluate the efficacy of the urinary detection of PCA3 mRNA and PSA mRNA without performing the somewhat embarrassing prostate massage. It was also intended to optimize and implement a methodological protocol for this kind of sampling. MATERIALS AND METHODS: Urine samples from 57 patients with suspected prostate disease were collected, without undergoing prostate massage. Increased serum PSA levels were confirmed by medical records review. RNA was extracted by different methods and a preamplification step was included in order to improve gene detection by Real-Time PCR. RESULTS: An increase in RNA concentration with the use of TriPure Isolation Reagent. Despite this optimization, only 15.8% of the cases showed expression of PSA mRNA and only 3.8% of prostate cancer patients presented detectable levels of PCA3 mRNA. The use of a preamplification step revealed no improvement in the results obtained. CONCLUSION: This work confirms that prostate massage is important before urine collection for gene expression analysis. Since PSA and PCA3 are prostate specific, it is necessary to promote the passage of cells from prostate to urinary tract, in order to detect these genetic markers in urine samples.
id SBU-1_fa0088c7767e44562fb378241a0f4364
oai_identifier_str oai:scielo:S1677-55382011000600006
network_acronym_str SBU-1
network_name_str International Braz J Urol (Online)
repository_id_str
spelling Controversies in using urine samples for prostate cancer detection: PSA and PCA3 expression analysisProstatic NeoplasmsBiomarkersUrineprostate-specific antigenPURPOSE: Prostate cancer (PCa) is one of the most commonly diagnosed malignancies in the world. Although PSA utilization as a serum marker has improved prostate cancer detection it still presents some limitations, mainly regarding its specificity. The expression of this marker, along with the detection of PCA3 mRNA in urine samples, has been suggested as a new approach for PCa detection. The goal of this work was to evaluate the efficacy of the urinary detection of PCA3 mRNA and PSA mRNA without performing the somewhat embarrassing prostate massage. It was also intended to optimize and implement a methodological protocol for this kind of sampling. MATERIALS AND METHODS: Urine samples from 57 patients with suspected prostate disease were collected, without undergoing prostate massage. Increased serum PSA levels were confirmed by medical records review. RNA was extracted by different methods and a preamplification step was included in order to improve gene detection by Real-Time PCR. RESULTS: An increase in RNA concentration with the use of TriPure Isolation Reagent. Despite this optimization, only 15.8% of the cases showed expression of PSA mRNA and only 3.8% of prostate cancer patients presented detectable levels of PCA3 mRNA. The use of a preamplification step revealed no improvement in the results obtained. CONCLUSION: This work confirms that prostate massage is important before urine collection for gene expression analysis. Since PSA and PCA3 are prostate specific, it is necessary to promote the passage of cells from prostate to urinary tract, in order to detect these genetic markers in urine samples.Sociedade Brasileira de Urologia2011-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382011000600006International braz j urol v.37 n.6 2011reponame:International Braz J Urol (Online)instname:Sociedade Brasileira de Urologia (SBU)instacron:SBU10.1590/S1677-55382011000600006info:eu-repo/semantics/openAccessFontenete,S.Silva,J.Teixeira,A. L.Ribeiro,R.Bastos,E.Pina,F.Medeiros,R.eng2012-02-16T00:00:00Zoai:scielo:S1677-55382011000600006Revistahttp://www.brazjurol.com.br/ONGhttps://old.scielo.br/oai/scielo-oai.php||brazjurol@brazjurol.com.br1677-61191677-5538opendoar:2012-02-16T00:00International Braz J Urol (Online) - Sociedade Brasileira de Urologia (SBU)false
dc.title.none.fl_str_mv Controversies in using urine samples for prostate cancer detection: PSA and PCA3 expression analysis
title Controversies in using urine samples for prostate cancer detection: PSA and PCA3 expression analysis
spellingShingle Controversies in using urine samples for prostate cancer detection: PSA and PCA3 expression analysis
Fontenete,S.
Prostatic Neoplasms
Biomarkers
Urine
prostate-specific antigen
title_short Controversies in using urine samples for prostate cancer detection: PSA and PCA3 expression analysis
title_full Controversies in using urine samples for prostate cancer detection: PSA and PCA3 expression analysis
title_fullStr Controversies in using urine samples for prostate cancer detection: PSA and PCA3 expression analysis
title_full_unstemmed Controversies in using urine samples for prostate cancer detection: PSA and PCA3 expression analysis
title_sort Controversies in using urine samples for prostate cancer detection: PSA and PCA3 expression analysis
author Fontenete,S.
author_facet Fontenete,S.
Silva,J.
Teixeira,A. L.
Ribeiro,R.
Bastos,E.
Pina,F.
Medeiros,R.
author_role author
author2 Silva,J.
Teixeira,A. L.
Ribeiro,R.
Bastos,E.
Pina,F.
Medeiros,R.
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Fontenete,S.
Silva,J.
Teixeira,A. L.
Ribeiro,R.
Bastos,E.
Pina,F.
Medeiros,R.
dc.subject.por.fl_str_mv Prostatic Neoplasms
Biomarkers
Urine
prostate-specific antigen
topic Prostatic Neoplasms
Biomarkers
Urine
prostate-specific antigen
description PURPOSE: Prostate cancer (PCa) is one of the most commonly diagnosed malignancies in the world. Although PSA utilization as a serum marker has improved prostate cancer detection it still presents some limitations, mainly regarding its specificity. The expression of this marker, along with the detection of PCA3 mRNA in urine samples, has been suggested as a new approach for PCa detection. The goal of this work was to evaluate the efficacy of the urinary detection of PCA3 mRNA and PSA mRNA without performing the somewhat embarrassing prostate massage. It was also intended to optimize and implement a methodological protocol for this kind of sampling. MATERIALS AND METHODS: Urine samples from 57 patients with suspected prostate disease were collected, without undergoing prostate massage. Increased serum PSA levels were confirmed by medical records review. RNA was extracted by different methods and a preamplification step was included in order to improve gene detection by Real-Time PCR. RESULTS: An increase in RNA concentration with the use of TriPure Isolation Reagent. Despite this optimization, only 15.8% of the cases showed expression of PSA mRNA and only 3.8% of prostate cancer patients presented detectable levels of PCA3 mRNA. The use of a preamplification step revealed no improvement in the results obtained. CONCLUSION: This work confirms that prostate massage is important before urine collection for gene expression analysis. Since PSA and PCA3 are prostate specific, it is necessary to promote the passage of cells from prostate to urinary tract, in order to detect these genetic markers in urine samples.
publishDate 2011
dc.date.none.fl_str_mv 2011-12-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382011000600006
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382011000600006
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S1677-55382011000600006
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Urologia
publisher.none.fl_str_mv Sociedade Brasileira de Urologia
dc.source.none.fl_str_mv International braz j urol v.37 n.6 2011
reponame:International Braz J Urol (Online)
instname:Sociedade Brasileira de Urologia (SBU)
instacron:SBU
instname_str Sociedade Brasileira de Urologia (SBU)
instacron_str SBU
institution SBU
reponame_str International Braz J Urol (Online)
collection International Braz J Urol (Online)
repository.name.fl_str_mv International Braz J Urol (Online) - Sociedade Brasileira de Urologia (SBU)
repository.mail.fl_str_mv ||brazjurol@brazjurol.com.br
_version_ 1750318072405688320